You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Reconfigurable Machining Center for Depot Productivity Enhancement
SBC: CREARE LLC Topic: AF161019Current depot-level manufacturing systems are not responsive to changing requirements and flexible specifications. The serial arrangement of individual work cells results in a lengthy timeline to complete the critically-needed part; thus, critical assets
SBIR Phase II 2017 Department of DefenseAir Force -
Cellular Immunotherapy for SSc
SBC: CELDARA MEDICAL, LLC Topic: NIAMSProject Summary Systemic sclerosis SSc is a systemic autoimmune disease that results in widespread fibrosis of the skin and internal organs vascular dropout and autoantibody formation SSc has the highest case fatality rate of any systemic autoimmune disease and there remain for FDA approved therapies Analysis of gene expression data on samples collected from SSc patients strongly indicates th ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Novel Inhibitors of PSMB and PSMB for the Treatment of Multiple Myeloma
SBC: InhiProt Topic: 103Multiple myeloma is incurable hematologic malignancy with an expected median survival of years The proteasome inhibitors bortezomib carfilzomib and the recently approved ixazomib are a mainstay of current myeloma treatment Despite an initial response rate approaching to proteasome inhibitor containing combinations all patients relapse and eventually become resistant to any treatments ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Evidence-Based Pain Intervention for Veterans: Leveraging Mobile and Social Media
SBC: Pro-Change Behavior Systems, Inc. Topic: NCCIHChronic musculoskeletal pain creates a significant public health burden, and Veterans are disproportionately affected. The frequency and extent of co-occurrence of pain and PTSD, pain and Traumatic Brain Injury (TBI), all three conditions (Post-deployment Multi-symptom Disorder (PMD), and other multi-symptom syndromes can complicate and reduce the effectiveness of pain treatment. Furthermore, the ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease
SBC: EPIVAX, INC. Topic: 200ABSTRACT SignificanceGravesdiseaseGDone of the most prevalent autoimmune diseasesis caused by stimulating autoantibodiesTSAbto the Thyroid Stimulating Hormone ReceptorTSHRresulting in hyperthyroidismCurrent methods for managing hyperthyroidism in GD target excess thyroid hormone secretion by ablation or removal of the thyroid or by blocking thyroid hormone synthesisEach of these therapies is assoc ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
SBC: Immunext, Inc. Topic: RImmuNext has identified and developed a putative lead anti VISTA monoclonal antibodymAbthat we aim to bring to the clinic for the treatment of human autoimmune diseaseVISTA is a member of the highly successful negative checkpoint regulatorNCRfamily of drug targetswhose members have demonstrated proven efficacy in inducing long term remissions in human cancersWe contend that antibodies that suppres ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Complex Dimensional in Vitro Human Skin Tissue Models for Scleroderma
SBC: CELDARA MEDICAL, LLC Topic: NIAMSAbstract Project Summary Scleroderma Systemic Sclerosis SSc is an autoimmune disease of unknown etiology that is characterized by vascular dysfunction fibrosis and inflammation One in three patients dies within years of diagnosis giving SSc the highest case fatality rate of any systemic autoimmune disease A lack of biologically relevant human SSc disease models has created a critical ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Open Source System for Audio Processing
SBC: CREARE LLC Topic: NIDCDThis proposal responds to RFA–DC-16-002, in which the NIDCD is seeking to support the development of acoustic signal processing tools that have the potential to accelerate research studies and to facilitate the translation of novel algorithms for hearing aids. Approximately 15% of American adults report some degree of hearing trouble, and 12.7% of Americans aged 12 and over experience bilateral ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Breast Cancer Locator
SBC: CAIRNSURGICAL, INC. Topic: 101PROJECT SUMMARY ABSTRACTCairnSurgical LLCa Dartmouth spin off companywill optimize and test multi site clinical feasibility of a new image guided intervention devicethe Breast Cancer LocatorBCLin breast conserving surgeryBCStoieliminate wire localizationa moderately effectivesomewhat costly and certainly inconvenient procedure for patients and surgeonsand concomitantly toiireduce positive margin r ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Antimony-based LWIR detectors with low dark current and high quantum efficiency
SBC: QMAGIQ LLC Topic: AF171078QmagiQ, LLC proposes to fabricate and deliver for evaluation a number of small-format focal plane arrays (FPAs) of antimony-based strained layer superlattice (SLS) photodiodes with longwave infrared (LWIR) cutoff wavelengths ranging from 9 microns to 13 m
SBIR Phase I 2017 Department of DefenseAir Force